Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway
- PMID: 30431104
- DOI: 10.3892/or.2018.6853
Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway
Abstract
Renal cell carcinoma (RCC) is one of the most common types of cancer of the urinary tract in the world. Long non‑coding RNA MALAT1 (lncR‑MALAT1) is upregulated in RCC and is associated with the proliferation and migration of RCC. The present study aimed to investigate the regulating role of lncR‑MALAT1 in RCC as well as the possible underlying mechanisms. The relative expression of MALAT1 and miR‑22‑3p in RCC tumor tissues and cell lines was detected by qRT‑PCR. CCK‑8 and wound healing assay were used to evaluate cell proliferation and migration ability. Western blot analysis was used to detect the expression of Ki‑67, proliferating cell nuclear antigen (PCNA), matrix metalloproteinase‑3 (MMP‑3), migration and invasion inhibitory protein (MIIP), p‑PI3K and p‑Akt. The relationship between MALAT1 and miR‑22‑3p was examined by bioinformatic prediction analysis and luciferase reporter assay. Immunofluorescence was used to detect the activation of Akt. MALAT1 was highly expressed and the expression of miR‑22‑3p was suppressed in RCC tissues and cell lines. ShRNA‑mediated knockdown of MALAT1 significantly inhibited the viability and mobility of RCC cells in vitro and in vivo. Further experiments revealed that miR‑22‑3p was a target of MALAT1 and that miR‑22‑3p inhibitor abolished the effect of MALAT1 shRNA on cell proliferation, migration and inactivation of PI3K/AKT pathway. In conclusion, lncR‑MALAT1 affected the proliferation and migration of RCC cells by targeting miR‑22‑3p through the inactivation of the PI3K/Akt signaling pathway.
Similar articles
-
lncRNA PVT1 in the Pathogenesis and Clinical Management of Renal Cell Carcinoma.Biomolecules. 2021 Apr 29;11(5):664. doi: 10.3390/biom11050664. Biomolecules. 2021. PMID: 33947142 Free PMC article. Review.
-
Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.Cell Cycle. 2020 Aug;19(16):2054-2062. doi: 10.1080/15384101.2020.1792667. Epub 2020 Jul 14. Cell Cycle. 2020. PMID: 32663095 Free PMC article.
-
miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.Oncol Rep. 2019 Nov;42(5):1677-1688. doi: 10.3892/or.2019.7307. Epub 2019 Sep 10. Oncol Rep. 2019. PMID: 31545453 Free PMC article.
-
LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):198-206. doi: 10.26355/eurrev_201901_16765. Eur Rev Med Pharmacol Sci. 2019. PMID: 30657561
-
MicroRNAs in Renal Cell Carcinoma.Microrna. 2015;4(1):26-35. doi: 10.2174/2211536604666150713105247. Microrna. 2015. PMID: 26165467 Review.
Cited by
-
CircPRELID2 functions as a promoter of renal cell carcinoma through the miR-22-3p/ETV1 cascade.BMC Urol. 2024 May 10;24(1):104. doi: 10.1186/s12894-024-01490-z. BMC Urol. 2024. PMID: 38730434 Free PMC article.
-
The functions of long non-coding RNA (lncRNA)-MALAT-1 in the pathogenesis of renal cell carcinoma.BMC Nephrol. 2023 Dec 20;24(1):380. doi: 10.1186/s12882-023-03438-1. BMC Nephrol. 2023. PMID: 38124072 Free PMC article. Review.
-
LncRNA MALAT1 Expression Regulates Breast Cancer Progression via PI3K/AKT/mTOR Pathway Modulation.Biochem Genet. 2023 Dec 18. doi: 10.1007/s10528-023-10592-6. Online ahead of print. Biochem Genet. 2023. PMID: 38110774
-
Transcription factor c-fos induces the development of premature ovarian insufficiency by regulating MALAT1/miR-22-3p/STAT1 network.J Ovarian Res. 2023 Jul 21;16(1):144. doi: 10.1186/s13048-023-01212-3. J Ovarian Res. 2023. PMID: 37480147 Free PMC article.
-
The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma.Int J Mol Sci. 2022 Dec 30;24(1):643. doi: 10.3390/ijms24010643. Int J Mol Sci. 2022. PMID: 36614082 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous